Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP)

Biomedicine and Pharmacotherapy

Volumn 59, Issue 10, 2005, Pages 561-570

  Oršolić, Nada ^a   Bašić, Ivan ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Antimetastatic effect; Chemoprevention; Colony forming units (CFUs); Hematopoiesis; Mice; Propolis; Radioprotection

Indexed keywords

ANTINEOPLASTIC AGENT; EPIRUBICIN; PROPOLIS; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD; BONE MARROW CELL; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOPENIA; ERYTHROCYTE COUNT; HEMATOPOIESIS; HEMATOPOIETIC TISSUE; INOCULATION; LEUKOCYTE COUNT; LUNG METASTASIS; MEGAKARYOCYTE; METASTASIS INHIBITION; MOUSE; MOUSE STRAIN; NONHUMAN; PARAMETER; PRIORITY JOURNAL; RADIATION PROTECTION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BLOOD CELL COUNT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; EPIRUBICIN; FEMALE; GAMMA RAYS; HEMATOPOIESIS; INJECTIONS, INTRAPERITONEAL; LEUKOPENIA; LUNG NEOPLASMS; MACROPHAGES, PERITONEAL; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED CBA; NEOPLASM TRANSPLANTATION; PROPOLIS; RADIATION-PROTECTIVE AGENTS; SOLUBILITY; TIME FACTORS;

EID: 29244432234     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2005.03.013     Document Type: Article

References (62)

1. M. Lahouel, G. Viotte, E. Sumereau, J.P. Morin, and J.P. Fillastre Haematotoxicity of doxorubicin and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and of their association in rats Drugs Exp. Clin. Res. 13 1987 593 599
2. J.P. Fillastre, G. Viotte, J.P. Morin, and B. Moulin Nephrotoxicity of antitumoral agents Adv. Nephrol. Necker Hosp. 17 1988 175 218
3. B.A. Chabner, and C.E. Myers Antitumor antibiotics V.T. De Vita S. Hellman S.A. Rosenberg Cancer: Principles and Practice of Oncology, AJF 1993 Lippincott Philadelphia 374 385
4. M. Martin-Richard, M. Munoz, J. Albanell, L. Colomo, M. Bellet, and M.J. Rey Serial topoisomerase II expression in primary breast cancer and response to neoadjuvant anthracycline-based chemotherapy Oncology 66 2004 388 394
5. R.W. Anderson, and N.L. Warner Ionizing radiation and the immune response Adv. Immunol. 24 1976 215 218
6. U.H. Behling A. Nowotny The radioprotective effect of bacterial endotoxin. In Beneficial effects of Endotoxin 1983 Plenum Press New York 127 131
7. B. Havsteen Flavonoids, a class of natural products of high pharmacological potency Biochem. Pharmacol. 32 1983 1141 1148
8. M. Wleklik, R. Zahorska, and V. Luczak Interferon-inducing activity of flavonoids Acta Microbiol. Pol. 32 1997 1141 1148
9. N. Oršolić, and I. Bašić Immunomodulatory action of a water-soluble derivative of propolis, caffeic acid and caffeic acid phenethyl ester: nitric oxide and macrophage function Mellifera 3 2003 56 64
10. N. Oršolić, and I. Bašić Immunomodulation by water-soluble derivative of propolis (WSDP) a factor of antitumor reactivity J. Ethnopharmacol. 84 2003 265 273
11. M. Moreno, M. Isla, A. Sampietro, and M. Vattuone comparison of the free radical-scavenging activity of propolis from several regions of Argentina J. Ethnopharmacol. 71 2000 109 114
12. M. Lahouel, S. Boulkour, N. Segueni, and J.P. Fillastre Protective effect of flavonoides against the toxicity of vinblastine, cyclophoshamide and paracetamol by inhibition of lipid-peroxydation and increase of liver glutathione Haema 7 2004 59 67
13. Y. Sadzuka, T. Sugiyama, K. Shimoi, N. Kinae, and S. Hirota Protective effect of flavonoids on doxorubicin-induced cardiotoxicity Toxicol. Lett. 92 1997 1 7
14. E. Ghisalberti Propolis: a review Bee World. 60 1979 59 84
15. P. Walker, and E. Crane Constituents of propolis Apidologie (Celle) 18 1987 327 334
16. A. Stojko, and S. Scheller Biological properties and clinical application of propolis VIII Arzneim-Forsch/Drug Res 28 1987 35 37
17. S. Scheller, and A. Stojko Biological properties and clinical application of propolis VI Arzneim-Forsch/Drug Res 27 1977 2138 2140
18. S. Scheller, T. Wilczok, S. Imielski, W. Krol, J. Gabrys, and J. Shani Free radical scavenging by ethanol extract of propolis Int. J. Radiat. Biol. 57 1990 461 465
19. M.C. Marcucci Propolis: chemical composition, biological properties and therapeutic activity Apidologie (Celle) 26 1995 83 99
20. M. Amoros, F. Sauvager, and L. Girre In vitro anti viral activity of propolis Apidologie (Celle) 23 1992 231 245
21. M. Debiaggi, F. Tateo, and L. Pagani Effects of propolis flavonoids on virus infectivity and replication Microbiologica 13 1990 207 213
22. M. Amoros, E. Lurton, and J. Boustie Comparison of the anti-herpex simplex virus activities of propolis and 3-methylbut-2-enyl caffeate J. Nat. Prod. 57 1994 644 647
23. W. Brumfitt Hamillton-Miller JTM, Franklin I, Antibiotic activity of natural products: 1. Propolis Microbios 62 1990 19 22
24. J.M. Grange, and R.W. Davey Antibacterial properties of propolis (bee glue) J. R. Soc. Med. 83 1990 159 160
25. J. Focht, S.H. Hansen, and J.V. Nielsen Bactericidal effect of propolis in vitro against agents causing upper respiratory tract infections Arzneim-Forsch/Drug Res 43 1993 921 924
26. A. La Torre, M. Guccione, and G. Imbroglini Indagine preliminary sull'azione di preparati a base di propoli nei confronti di Botrytis cinerea Pers della fragola Apicoltura 6 1990 169 177
27. G.A. Lori Accion fungicida del propoleos en la dermatomicosis bovina Ind. Apic 1 1990 38 43
28. J. Ban, Š. Popović, and D. Maysinger Cytostatic effect of propolis in vitro Acta Pharm. Jugosl. 33 1983 245 255
29. S. Scheller, W. Krol, J. Swiacik, S. Owczarek, J. Gabrys, and J. Shani Antitumoral property of ethanolic extract of propolis in mice bearing Ehrlich carcinoma, as compared to bleomycin Z. Naturforsch 44c 1989 1063 1065
30. C. Chiao, A.M. Carothers, D. Grunberger, G. Solomon, A.G. Preston, and C.J. Barrett Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells Cancer Res. 55 1995 3576 3583
31. C.V. Rao, D. Desai, A. Rivenson, B. Simi, S. Amin, and S.B. Reddy Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate Cancer Res. 55 1995 2310 2315
32. Bašić I, Oršolić N, Tadić Z, Macedo Fereire Alcici N, Brbot Šaranović A, Bendelja K, et al. Antimetastatic effect of propolis, caffeic acid phenethyl ester and caffeic acid on mammary carcinoma of CBA mouse. 17th International Cancer Congress, Rio de Jeneiro, Brazil, (ed.) M. Moraes, R. Brentani and R. Bevilaqua, 1988. pp 63-75.
33. N. Manolova, V. Maximova, Z. Manolova, I. Stoilova, E. Korczak, and A. Denis Immunobiological effect of propolis. I. Effect on cellular immunity Acta Microbiol. Bulg. 21 1987 76 81
34. H. Neychev, V. Dimov, V. Vuleva, L. Shirova, E. Slavcheva, and G. Gegova Immunomodulatory action of propolis. II. Effect of water-soluble fraction on influenza infection in mice Acta Microbiol. Bulg. 23 1988 58 62
35. V. Dimov, N. Ivanovska, V. Bankova, and S. Popov Immunodulatory action of propoolis. IV. Prophylactic activity against gram-negative infections and adjuvant effect of the water-soluble derivate Vaccine 10 1992 817 823
36. V. Dimov, N. Ivanovska, N. Manolova, V. Bankova, N. Nikolov, and S. Popov Immunodulatory action of propolis. Influence on anti-infectious protection and macrophage function Apidologie (Celle) 22 1991 155 162
37. Foster RS. Effects of Corynebacterium parvum on granulocyte/macrophage production and toxicity of chemotherapy. In Developments of Biological Standardization. (Edited by the International Association of Biological Standardization) 1978. Vol. 38, p. 245, S. Karger, Basel.
38. N. Nikolov, N. Marekov, V. Bankova, S. Popov, R. Ignatova, and I. Vladimirova Method for the preparation of water-soluble derivative of propolis Bul. Pat. Appl. 1987 (79903/28, 05)
39. I. Bašić, and E. Varga Immunogenicity of mammary carcinoma and a fibrosarcoma of CBA mice Period Biol. 81 1979 335 337
40. J.L. Curry, and J.J. Trentin Hemopoietic spleen colony studies. I. Growth and differentiation Dev. Biol. 15 1967 395 399
41. L. Milas, and I. Bašić I. Éupar Proceedings of Symposium on Malignant Tumours of the Head and Neck 1972 Yugoslav Academy of Sciences and Arts Zagreb 37 45
42. M.S. Meltzer, and J.J. Oppenheim Bidirectional amplification of macrophage-lymphocyte activation factor production by activated adherent mouse peritoneal cells J. Immunol. 118 1977 77 82
43. F. Tietze Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues Anal. Biochem. 27 1969 502 522
44. L. Siminovitch, E.A. McCulloch, and J.E. Till The distribution of colony-forming cells among spleen colonies J. Cell. Comp. Physiol. 62 1963 327 331
45. S. Scheller, W. Krol, J. Swiacik, S. Owczarek, J. Gabrys, and J. Szumlas Antitumoral property of ethanolic extract of propolis in mice-bearing Ehrlich carcinoma, as compared to bleomycin Z. Naturforsch 44c 1989 1063 1065
46. G. Galati, S. Teng, M.Y. Moridani, T.S. Chan, and P.J. O'Brien Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics Drug Metabol. Drug Interact. 17 2000 311 349
47. S. Caltagirone, C. Rossi, A. Poggi, F.O. Ranelletti, P.G. Natali, and M. Brunetti Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential Int. J. Cancer 87 2000 595 600
48. I. Suzuki, I. Hayashi, T. Takaki, D.S. Groveman, and Y. Fujimiya Antitumor and anticytopenic effects of aqueous extracts in combination with chemotherapeutic agents Cancer Biother. Radiopharm. 17 2002 553 562
49. R. Neta Douches and Oppenheim JJ. Interleukin 1 is a radiorotector J. Immunol. 136 1986 2483 2485
50. V. Maruyama, C. Magura, and J. Feoba Corynebacterium parvum-induced, diosensitivity and cyclic changes of hematopoietic spleen colony-forming units J. Natl. Cancer Inst. 59 1977 173 178
51. M.Y. Gordon, M. Aguado, and N.M. Blackett Effect of BCG and Corynebacterium parvum on the hematopoietc precusor cell in contineusly irradiated mice: possible mechanisms of action in immunotherapy Eur. J. Cancer 13 1977 229 233
52. I. Bašić, and L. Milas Effect of whole body irradiation on mice treated with Corynebacterium parvum Eur. J. Cancer 13 1979 901 908
53. W.R. Bezwoda, D. Lewis, and N. Livini Bone marrow involvement in anaplastic small cell lung cancer. Diagnosis, hematologic features, and prognostic implications Cancer 58 1986 1762 1767
54. A. Meister Glutathione, ascorbate, and cellular protection Cancer Res. 54 1994 1969 1975
55. J.K. Dethmers, and A. Meister Glutathione exports by human lymphoid cells: depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation Proc. Natl. Acad. Sci. USA 78 1981 7492 7497
56. A. Meister Glutathione deficiency produced by inhibition of its synthesis and its reversal; application in research and therapy Pharmacol. Ther. 51 1991 155 159
57. T. Hamilton, P. O'Dwyer, and R. Yong Phase I trial of buthionine sulfoximine (BSO) plus melphalan (L-PAM) in patients with advanced cancer Proc. A. Meet. Am. Soc. Clin. Oncol. 9 1990 A281
58. N. Orsolić, K. Bendelja, A. Brbot-Šaranović, and I. Bašić (2004) Effects of caffeic acid phenethyl ester and caffeic acid, antioxidants from propolis, on inducing apoptosis in HeLa human cervical carcinoma and Chinese hamster lung V79 fibroblast cells Period Biol. 106 2004 367 372
59. R.H. Burdon Superoxide and hydrogen peroxide in relation to mammalian cell proliferation Free Radic. Biol. Med. 18 1995 775 794
60. P. Terradez, M. Asensi, M.C. Lasso de la Vega, I.R. Puertes, J. Vina, and J.M. Estrela Depletion of tumor glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth Biochem. J. 292 1993 477 483
61. T.J. Kavanagh, A. Grossmann, E.P. Jaecks, J.C. Jinneman, D.L. Eaton, and G.M. Martin Proliferative capacity of human peripheral blood lymphocytes sorted on the basis of glutathione content J. Cell. Physiol. 145 1990 472 480
62. M.J. Smyth Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function J. Immunol. 146 1991 1921 1927